NUCLEATE LIMITED

Company number 09584553 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£100k £0 £100k £200k £300k £400k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £103,596 Total assets 2017: £110,390 Total assets 2018: £98,249 Total assets 2019: £95,290 Total assets 2020: £154,824 Total assets 2021: £199,976 Total assets 2022: £203,064 Total assets 2023: £240,065 Total assets 2024: £220,718 Total assets 2025: £316,134 Total assets Net assets 2016: £76,252 Net assets 2017: £64,379 Net assets 2018: £54,403 Net assets 2019: £51,152 Net assets 2020: £74,234 Net assets 2021: £107,505 Net assets 2022: £125,818 Net assets 2023: £126,844 Net assets 2024: £112,178 Net assets 2025: £279,657 Net assets Total liabilities 2016: -£26,594 Total liabilities 2017: -£31,309 Total liabilities 2018: -£24,657 Total liabilities 2019: -£36,158 Total liabilities 2020: -£47,234 Total liabilities 2021: -£47,234 Total liabilities 2022: -£38,254 Total liabilities 2023: -£82,174 Total liabilities 2024: -£86,932 Total liabilities 2025: -£34,477 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 0 0 1 1 1 1 2 2024 2025 2024: 2 2025: 2

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 10 years

Latest accounts (2025-05-31): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-05-31 £316,134 -£34,477 £279,657 2
2024-05-31 £220,718 -£86,932 £112,178 2
2023-05-31 £240,065 -£82,174 £126,844
2022-05-31 £203,064 -£38,254 £125,818
2021-05-31 £199,976 -£47,234 £107,505
2020-05-31 £154,824 -£47,234 £74,234
2019-05-31 £95,290 -£36,158 £51,152
2018-05-31 £98,249 -£24,657 £54,403 £50,178
2017-05-31 £110,390 -£31,309 £64,379 £38,276
2016-05-31 £103,596 -£26,594 £76,252

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.